Latest Insider Transactions at Staar Surgical CO (STAA)
This section provides a real-time view of insider transactions for Staar Surgical CO (STAA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of STAAR SURGICAL CO to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of STAAR SURGICAL CO's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 10
2023
|
Samuel J Gesten Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
280
-0.82%
|
$15,680
$56.63 P/Share
|
|
Mar 10
2023
|
James E Francese Sr. VP, Comm. Ops., NA, APAC |
BUY
Exercise of conversion of derivative security
|
Direct |
8,388
+16.52%
|
-
|
|
Mar 10
2023
|
James E Francese Sr. VP, Comm. Ops., NA, APAC |
SELL
Payment of exercise price or tax liability
|
Direct |
250
-0.73%
|
$14,000
$56.63 P/Share
|
|
Mar 07
2023
|
James E Francese Sr. VP, Comm. Ops., NA, APAC |
BUY
Exercise of conversion of derivative security
|
Direct |
1,083
+2.98%
|
$62,814
$58.13 P/Share
|
|
Mar 07
2023
|
James E Francese Sr. VP, Comm. Ops., NA, APAC |
SELL
Payment of exercise price or tax liability
|
Direct |
672
-1.93%
|
$38,976
$58.13 P/Share
|
|
Mar 07
2023
|
Samuel J Gesten Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,338
+3.65%
|
$77,604
$58.13 P/Share
|
|
Mar 07
2023
|
Samuel J Gesten Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
831
-2.39%
|
$48,198
$58.13 P/Share
|
|
Mar 07
2023
|
Keith Holliday Chief Technology Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,431
+6.68%
|
$82,998
$58.13 P/Share
|
|
Mar 07
2023
|
Keith Holliday Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
889
-4.57%
|
$51,562
$58.13 P/Share
|
|
Mar 07
2023
|
Robert Studholme Senior VP, Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
1,709
+6.88%
|
$99,122
$58.13 P/Share
|
|
Mar 07
2023
|
Patrick F. Williams Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,711
+4.6%
|
$99,238
$58.13 P/Share
|
|
Mar 07
2023
|
Patrick F. Williams Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,063
-3.05%
|
$61,654
$58.13 P/Share
|
|
Mar 07
2023
|
Scott D Barnes Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,603
+4.75%
|
$92,974
$58.13 P/Share
|
|
Mar 07
2023
|
Scott D Barnes Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
777
-2.48%
|
$45,066
$58.13 P/Share
|
|
Jan 03
2023
|
Thomas G Frinzi President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
87,805
+48.69%
|
-
|
|
Dec 29
2022
|
Broadwood Partners, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
0
|
-
|
|
Dec 29
2022
|
Broadwood Partners, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
39,090
+0.44%
|
$1,837,230
$47.93 P/Share
|
|
Dec 28
2022
|
Broadwood Partners, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
0
|
-
|
|
Dec 28
2022
|
Broadwood Partners, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
100,000
+1.13%
|
$4,600,000
$46.98 P/Share
|
|
Dec 27
2022
|
Broadwood Partners, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
0
|
-
|
|
Dec 27
2022
|
Broadwood Partners, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
51,985
+0.6%
|
$2,443,295
$47.91 P/Share
|
|
Sep 27
2022
|
James E Francese Sr. VP, Comm. Ops., NA, APAC |
SELL
Open market or private sale
|
Direct |
35,425
-23.3%
|
$2,656,875
$75.0 P/Share
|
|
Sep 27
2022
|
James E Francese Sr. VP, Comm. Ops., NA, APAC |
BUY
Exercise of conversion of derivative security
|
Direct |
13,075
+21.41%
|
$91,525
$7.52 P/Share
|
|
Aug 15
2022
|
Keith Holliday Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
16,582
-26.35%
|
$1,757,692
$106.27 P/Share
|
|
Aug 15
2022
|
Keith Holliday Chief Technology Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,582
+9.57%
|
$312,714
$27.31 P/Share
|
|
Jun 16
2022
|
Stephen C Farrell |
BUY
Exercise of conversion of derivative security
|
Direct |
355
+5.13%
|
-
|
|
Jun 16
2022
|
Thomas G Frinzi President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,805
+16.62%
|
-
|
|
Jun 16
2022
|
Gilbert H Kliman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,254
+20.67%
|
-
|
|
Jun 16
2022
|
Elizabeth Yeu Lin |
BUY
Exercise of conversion of derivative security
|
Direct |
355
+50.0%
|
-
|
|
Jun 16
2022
|
K Peony Yu Director |
BUY
Exercise of conversion of derivative security
|
Direct |
355
+24.79%
|
-
|
|
Jun 07
2022
|
Patrick F. Williams Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,121
+12.81%
|
-
|
|
Jun 06
2022
|
Caren L Mason President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
68,770
+11.46%
|
$687,700
$10.18 P/Share
|
|
May 20
2022
|
Caren L Mason President & CEO |
SELL
Open market or private sale
|
Direct |
35,000
-29.5%
|
$2,030,000
$58.48 P/Share
|
|
May 20
2022
|
Caren L Mason President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
35,000
+22.78%
|
$315,000
$9.3 P/Share
|
|
May 19
2022
|
Caren L Mason President & CEO |
SELL
Open market or private sale
|
Direct |
35,000
-29.5%
|
$1,995,000
$57.49 P/Share
|
|
May 19
2022
|
Caren L Mason President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
35,000
+22.78%
|
$315,000
$9.3 P/Share
|
|
May 18
2022
|
Caren L Mason President & CEO |
SELL
Open market or private sale
|
Direct |
35,000
-29.5%
|
$1,960,000
$56.46 P/Share
|
|
May 18
2022
|
Caren L Mason President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
35,000
+22.78%
|
$315,000
$9.3 P/Share
|
|
Mar 21
2022
|
James E Francese Sr. VP, Comm. Ops., NA, APAC |
SELL
Open market or private sale
|
Direct |
922
-1.58%
|
$68,228
$74.62 P/Share
|
|
Mar 14
2022
|
James E Francese Sr. VP, Comm. Ops., NA, APAC |
SELL
Open market or private sale
|
Direct |
289
-0.49%
|
$18,496
$64.18 P/Share
|
|
Mar 07
2022
|
Scott D Barnes Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,991
+20.33%
|
-
|
|
Mar 07
2022
|
Hans Martin Blickensdoerfer Sr. VP, Comm. Ops, China |
BUY
Exercise of conversion of derivative security
|
Direct |
5,910
+6.64%
|
-
|
|
Mar 07
2022
|
James E Francese Sr. VP, Comm. Ops., NA, APAC |
BUY
Exercise of conversion of derivative security
|
Direct |
5,839
+9.08%
|
-
|
|
Mar 07
2022
|
Samuel J Gesten Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,216
+17.17%
|
-
|
|
Mar 07
2022
|
Keith Holliday Chief Technology Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,716
+24.0%
|
-
|
|
Mar 07
2022
|
Caren L Mason President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
20,269
+19.51%
|
-
|
|
Mar 07
2022
|
Patrick F. Williams Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,225
+20.93%
|
-
|
|
Dec 14
2021
|
Keith Holliday Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
6,000
-26.41%
|
$534,000
$89.57 P/Share
|
|
Nov 18
2021
|
Caren L Mason President & CEO |
SELL
Open market or private sale
|
Direct |
35,000
-35.58%
|
$3,955,000
$113.83 P/Share
|
|
Nov 18
2021
|
Caren L Mason President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
35,000
+26.24%
|
$245,000
$7.76 P/Share
|